Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | -24 | 12 | 5 | 9 | 11 |
| Operating Expenses | 214 | 111 | 154 | 116 | 61 |
| Operating Income | -237 | -99 | -148 | -107 | -51 |
| Other Income | 237 | 99 | 148 | 107 | 51 |
| Net Income Continuous | -248 | -99 | -148 | -107 | -51 |
| Net Income | $-248 | $-99 | $-148 | $-107 | $-51 |
| EPS Basic Total Ops | -0.09 | -0.04 | -0.04 | -0.04 | -0.02 |
| EPS Basic Continuous Ops | -0.09 | -0.04 | -0.04 | -0.04 | -0.02 |
| EPS Diluted Total Ops | -0.09 | -0.04 | -0.04 | -0.04 | -0.02 |
| EPS Diluted Continuous Ops | -0.09 | -0.04 | -0.04 | -0.04 | -0.02 |
| EBITDA(a) | $-233 | $-95 | $-144 | $-103 | $-45 |